CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges. read more
Exact Sciences Q3 EPS loss of $0.21 fell short of analyst expectations. 2024 revenue guidance lowered amid screening segment hurdles, growth plans set for 2025. Latest Ratings for EXAS Date Firm Action From To Feb 2022 Wells Fargo Maintains Equal-Weight Feb 2022 Citigroup Maintains Neutral Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings…
ODP Corporation misses Q3 earnings and sales expectations, lowers FY24 EPS guidance. Also, ODP entered a partnership with a large strategic reseller organization. read more
Broadcom expanded its multi-year partnership with Telia Company to advance telecom and cloud infrastructure using VMware’s product portfolio. read more
Latest Ratings for CLX Date Firm Action From To Feb 2022 DA Davidson Maintains Neutral Feb 2022 Barclays Maintains Underweight Feb 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for CLX View the Latest Analyst Ratings read more
American Electric Power Company reported Q3 revenue of $5.42B, missing consensus of $5.434B. Commercial load up 10%, projected to grow 20% annually. Adjusted EPS beat and outlook narrowed. read more
Theo, known as the French ‘Trump whale’, made $50 million on bets related to Trump winning the 2024 election. His accounts have also influenced the betting landscape. read more
Donald Trump has won the 2024 U.S. presidential election, paving the way for a significant shift in economic policy. His vision includes tax cuts and trade tariffs, while Kamala Harris proposed tax increases and a more restrained trade policy. read more
Trump’s presidency is anticipated to pivot U.S. energy policy back towards oil and gas production. read more